This page is under construction. This page is under construction.
 
     
 

CC-500® Antimicrobial Skin Cleanser

NDC #46706-102-01 Product Release: 1974
O-T-C Pharmaceutical

Indications and Usage

Topical, antimicrobial skin cleanser formulated for the treatment of patients with compromised immune systems. Proven effective in controlling skin eruptions and topical infection in Diabetic, HIV, Dialysis, and oncology patient care. High-lathering, free rinsing cleanser for professional patient bathing or as an antibacterial shampoo. CC-500® is a concentrate and demands very little product in routine usage. Contains moisturizers to soothe tender, dry skin of the geriatric patient. Excellent for usage on dialysis patients or in cases of skin odor or maladies demanding dermatological treatment and relief. Consists of the maximum level of surfactancy which aids in the removal of organic materials. Extremely effective in alleviating dermatitis and acne. Also effective in the treatment of Acne Mechanica, an acneiform eruption in athletes.

Clinical Pharmacology

CC-500® is a synergistic blend combining cationic, ionic and anionic surfactants with emollients to promote natural turgor and prevent dryness, scaling and dermal irritation. Hydration properties replenish natural emollients in dermal tissue promoting healthy tissue and skin turgor. Active antimicrobial agent rids skin of contaminants.

Active Ingredient: USP Chloroxylenol 0.8%

Precautions

  • External Use Only - Not for Ocular Use
  • Non-Toxic, Non-Dermal Irritant

Microbiology

  1. Draize Dermal Irritation Test - Non-Dermal Irritant
  2. Acute Oral Toxicity - LD50 > 15 g/kg. When evaluated by the criteria established in Title 16,
    Code of Federal Regulations, Part 1500.3 (FHSH), CC-500® is considered non-toxic.
  3. Scientific Associates/Kligman test of topical antimicrobial efficacy: Proliferation of microflora
    inhibited by 97.9% where CC-500® was applied.
  4. Zone of Inhibition (Fed. Circ. 198, USFDA) Staphylococcus aureus - Methicillin - resistant
    (MRSA): No Growth.
  5. Time Kill Study - 1 Min., 3 Min. & 5 Min.: S. aureus, P. aeruginosa, and S. typhimurium
    reduction of 99.9% in one minute contact.
  6. Broad Spectrum: The concentration of chloroxylenol in CC-500® is 8,000 ppm. The MIC _
    8,000 ppm. Gram negative and Gram positive bacteria.

Dosage and Administration

Anti-Infective - Hand Degerming

CC-500® is a concentrated, antimicrobial cleanser designed specifically to reduce the risk of skin breakdown and prevent the spread of infection. Use in daily hygiene programs, full body including hair and scalp. Use for medical personnel to reduce the risk of cross-contamination and aid in healing over-worked or chemically damaged hands.

Therapeutic Patient Care

CC-500® has been proven to be clinically effective at eliminating the sources of microbial infection at the exit site in dialysis patients and/or around ostomy sites to prevent skin breakdown. CC-500® can be used as a foot soak additive for diabetic feet maladies to eliminate odor and reduce the risk of tissue breakdown and bacterial infection. Diabetic patients should bathe daily in normal manner with CC-500®.

Available Product Sizes

Product Code Product Container Size Price  
C102-8ZEA CC-500 8.5-Ounce Bottle $21.95
C102-8Z CC-500 8.5-Ounce Bottle/24 per Case $198.00

« Back to Products by Specialty
« Back to Product List

 
     
 
     
  Home    Techni-Care    Products    Reference    Online Store    Contact Us    About    Terms of Use    Privacy Statement  
     
 
Copyright © 2006 Consolidated Chemical, Inc. & MedNet Technologies, Inc. All Rights Reserved
MedNet-Sites™ - Powered by MedNet Technologies, Inc
  MedNet-Sites by MedNet Technologies